Additionally, exploring the role of other regulatory microRNAs in modulating ABC transporter expression could unveil novel targets for combination therapies, ultimately leading to more effective treatment regimens for ovarian cancer patients. This evidence concerns the gene ABCG2 and ovarian carcinoma.